Methocarbamol News

FDA Safety Labeling Changes

The U.S. Food and Drug Administration (FDA) approved in May revisions to drug safety labeling to advise healthcare professionals of the following changes: fondaparinux sodium injection is contraindicated in low-weight patients...

Able Laboratories Receives FDA Approval for Methocarbamol Tablets, USP 500mg and 750mg

Able Laboratories, Inc. (Nasdaq:ABRX) (BSE:AAB), today announced that it has received Food and Drug Administration (FDA) approval for its Abbreviated New Drug Application (ANDA) for Methocarbamol Tablets, USP 500mg and 750mg....

Tremorgenic mycotoxicosis in four dogs from a single household

Mycotoxins are fungal metabolites that induce undesirable effects. The effects of these mycotoxins vary depending on the chemical structure of the toxin and degree of toxicity.

Major Company to Stop Making Generic Oral Products

Bethesda, MD — American Home Products Corp. (AHP) has announced that it will stop manufacturing and marketing generic oral drug products over the next several months.

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.